Free Access
Issue
Med Sci (Paris)
Volume 34, Number 5, Mai 2018
Page(s) 388 - 391
Section Le Magazine
DOI https://doi.org/10.1051/medsci/20183405006
Published online 13 June 2018
  1. Sadler AJ, Williams BR. Interferon-inducible antiviral effectors. Nat Rev Immunol 2008 ; 8 : 559–68. doi:10.1038/nri2314 [Google Scholar]
  2. Degols G, Eldin P, Mechti N. ISG20, an actor of the innate immune response. Biochimie 2007 ; 89 : 831–5. doi:10.1016/j.biochi.2007.03.006 [CrossRef] [PubMed] [Google Scholar]
  3. Wieland SF, Vega RG, Muller R, et al. Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol 2003 ; 77 : 1227–36. [CrossRef] [PubMed] [Google Scholar]
  4. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 2004 ; 101 : 6669–74. doi:10.1073/pnas.0401771101 [Google Scholar]
  5. Liu Y, Nie H, Mao R, et al. Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA. PLoS Pathog 2017 ; 13 : e1006296. doi:10.1371/journal.ppat.1006296 [CrossRef] [PubMed] [Google Scholar]
  6. Harris RS, Hultquist JF, Evans DT. The restriction factors of human immunodeficiency virus. J Biol Chem 2012 ; 287 : 40875–83. doi:10.1074/jbc.R112.416925 [CrossRef] [PubMed] [Google Scholar]
  7. Gerossier L, Decorsière A, Abdul F, Hantz O. Identification d’un nouveau facteur de restriction contre l’infection par le virus de l’hépatite B : le complexe SMC5/6. Med Sci (Paris) 2016 ; 32 : 808–12. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. Mueller H, Wildum S, Luangsay S, et al. A novel orally available small molecule that inhibits hepatitis B virus expression. J Hepatol 2017 ; doi:10.1016/j.jhep.2017.10.014 [Google Scholar]
  9. Zhou T, Block T, Liu F, et al. HBsAg mRNA degradation induced by a dihydroquinolizinone compound depends on the HBV posttranscriptional regulatory element. Antiviral Res 2018 ; 149 : 191–201. doi:10.1016/j.antiviral.2017.11.009 [CrossRef] [PubMed] [Google Scholar]
  10. Feng H, Beck J, Nassal M, Hu KH. A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication. PLoS One 2011 ; 6 : e27862. doi:10.1371/journal.pone.0027862. [CrossRef] [PubMed] [Google Scholar]
  11. Ko C, Lee S, Windisch MP, Ryu WS. DDX3 DEAD-box RNA helicase is a host factor that restricts hepatitis B virus replication at the transcriptional level. J Virol 2014 ; 88 : 13689–98. doi:10.1128/JVI.02035-14. [CrossRef] [PubMed] [Google Scholar]
  12. Xia Y, Protzer U. Control of hepatitis B virus by cytokines. Viruses 2017 ; 9. doi:10.3390/v9010018. [Google Scholar]
  13. Sato S, Li K, Kameyama T, Hayashi T, et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 2015 ; 42 : 123–32. doi:10.1016/j.immuni.2014.12.016. [CrossRef] [PubMed] [Google Scholar]
  14. Testoni B, Durantel D, Zoulim F. Novel targets for hepatitis B therapy. Liver Int 2017 ; 37 (suppl 1) : 33–9. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.